Insolvency Notices

Company

AZERIA THERAPEUTICS LIMITED

Notice Type
Notices to Creditors
Publication date
14/12/2020
Edition
The London Gazette
Notice ID
3694457
Notice Code
2433

AZERIA THERAPEUTICS LIMITED

(Company Number 10659547)

Registered office: 4 Claridge Court, Lower Kings Road, Berkhamsted, Hertfordshire, HP4 2AF

Principal trading address: Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE

Notice is hereby given that Creditors of the Company are required, on or before 21 January 2021, to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England and Wales) Rules 2016 to the Joint Liquidators at Smith & Williamson LLP, 4th Floor Cumberland House, 15-17 Cumberland Place, Southampton, SO15 2BG.

If so required by notice from the Joint Liquidators, creditors must produce any document or other evidence which the Joint Liquidators consider is necessary to substantiate the whole or any part of a claim.

Note: The Directors of the Company have made a declaration of solvency and it is expected that all creditors will be paid in full.

Date of Appointment: 8 December 2020.

Office Holder Details: Stephen John Adshead (IP No. 8574) and Gregory Andrew Palfrey (IP No. 9060) both of Smith & Williamson LLP, 4th Floor Cumberland House, 15-17 Cumberland Place, Southampton, SO15 2BG

For further details contact: The Joint Liquidators, Tel: 02380 827600. Alternative contact: Danny Hackling.

Stephen John Adshead, Joint Liquidator

10 December 2020

Ag ZG90906